Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Stoke Therapeutics, Inc.
- Avidity Biosciences, Inc.
Updated Jul 16, 2026
LEVIN ARTHUR A has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.64M.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-17 | STOK | Stoke Therapeutics, Inc. | S — Open-market sale [10b5-1] | 605 | $36.80 | $22K |
| 2026-02-27 | RNAM | Avidity Biosciences, Inc. | D — Derivative transaction | 131.4K | — | |
| 2026-02-27 | RNAM | Avidity Biosciences, Inc. | D — Derivative transaction | 16.6K | — | |
| 2026-01-23 | RNAM | Avidity Biosciences, Inc. | S — Open-market sale [10b5-1] | 1.8K | $72.45 | $127K |
| 2025-09-30 | STOK | Stoke Therapeutics, Inc. | M — Option exercise | 1.2K | $0.00 | |
| 2025-08-06 | RNAM | Avidity Biosciences, Inc. | S — Open-market sale | 107.5K | $47.62 | $5.12M |
| 2025-08-06 | RNAM | Avidity Biosciences, Inc. | M — Option exercise | 107.5K | $22.34 | $2.40M |
| 2025-06-30 | STOK | Stoke Therapeutics, Inc. | M — Option exercise | 1.2K | $0.00 | |
| 2025-06-10 | RNAM | Avidity Biosciences, Inc. | A — Grant or award | 6.7K | $0.00 | |
| 2025-03-31 | STOK | Stoke Therapeutics, Inc. | M — Option exercise | 1.2K | $0.00 | |
| 2024-11-20 | RNAM | Avidity Biosciences, Inc. | S — Open-market sale [10b5-1] | 3.3K | $42.12 | $140K |
| 2024-11-20 | RNAM | Avidity Biosciences, Inc. | M — Option exercise [10b5-1] | 3.3K | $1.24 | $4K |
| 2024-10-23 | RNAM | Avidity Biosciences, Inc. | S — Open-market sale [10b5-1] | 5.0K | $46.63 | $233K |
| 2024-10-23 | RNAM | Avidity Biosciences, Inc. | M — Option exercise [10b5-1] | 5.0K | $1.24 | $6K |
LEVIN ARTHUR A is a corporate insider — currently tracked as Insider of Stoke Therapeutics, Inc. (STOK). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($5.64M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LEVIN ARTHUR A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.